Home | Welcome to Contract Pharma   
Last Updated Friday, October 31 2014
Print RSS Feed

Search Results for 'Novartis, MorphoSys Expand Antibody Alliance'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published November 14, 2012
Incorporates new technology platforms Read More »
Published December 3, 2007
Novartis and MorphoSys AG have formed a comprehensive, 10-year, $600 million strategic alliance for the discovery and development of biopharmaceuticals. The deal is aimed at establishing a pipeline of innovative drugs, and establishes Novartis as Mor… Read More »
Published June 26, 2006
MorphoSys AG expanded its therapeutic antibody collaboration with Novartis. The original collaboration agreement provided for a three-year term with an option for Novartis to extend. The collaboration will now go through May 2011. In May 2004,… Read More »
By Mr. Deepak Bahri, President
By WITec GmbH
By Anna Shagako, Clinical Operations Head
By Business Development
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On